| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Interest income: |
| Interest income on loans | 11.1 | 12.6 | 13.1 | 13.8 | 13.3 | 13.0 | 14.2 | 14.8 |
| Interest income on investments | 4.5 | 3.9 | 2.1 | 1.7 | 1.7 | 1.6 | 1.3 | 1.3 |
| | 16.0 | 16.6 | 15.4 | 15.9 | 15.2 | 15.0 | 15.8 | 16.1 |
| Interest expense: |
| Interest on deposits | 2.0 | 0.8 | 1.5 | 3.0 | 2.4 | 1.4 | 0.9 | 0.7 |
| | 2.2 | 0.8 | 1.6 | 3.2 | 2.7 | 1.4 | 1.0 | 0.9 |
| Net interest income | 21.6 | 19.5 | 17.7 | 17.7 | 17.1 | 17.1 | 17.5 | 18.4 |
| Net interest income after provision for loan losses | 21.6 | 19.5 | 17.7 | 17.7 | 17.1 | 17.1 | 17.5 | 18.4 |
| Deposit and loan fees | | | | | | | | 4.3 |
| Gain on sale of investments, net | | | | | | | | 1.7 |
| Other non-interest income | 6.9 | 6.5 | 7.3 | 6.5 | 6.4 | 7.0 | 6.5 | -2.0 |
| Total non-interest income | 6.9 | 6.5 | 7.3 | 6.5 | 6.4 | 7.0 | 6.5 | 4.0 |
| Non-interest expenses | 21.9 | 22.6 | 21.5 | 22.5 | 22.8 | 22.3 | 23.2 | 0.1 |
| Equity in earnings | | | | | | 0.0 | | |
| Pre-tax income before non-recurring items | 6.5 | 9.0 | -2.2 | 1.7 | 0.6 | 1.7 | 0.2 | -4.6 |
| Non-recurring items | | | 0.3 | | | | | |
| Pre-tax income | 6.5 | 9.0 | -2.6 | 1.7 | 0.6 | 1.7 | 0.2 | -4.6 |
| Income taxes | -2.4 | 0.1 | 0.0 | 0.0 | 0.0 | -1.1 | 0.1 | 0.0 |
| Tax rate | | 0.7% | 0.0% | 0.0% | | | 31.8% | 0.0% |
| Net income | 8.9 | 8.9 | -2.6 | 1.7 | 0.6 | 2.8 | 0.2 | -4.6 |
| Net margin | 31.4% | 34.4% | -10.2% | 6.9% | 2.7% | 11.5% | 0.7% | -20.5% |
| |
| Basic EPS | $1.91 | $1.84 | ($0.52) | $0.34 | $0.13 | $0.54 | $0.03 | ($0.90) |
| Diluted EPS | $1.91 | $1.84 | ($0.52) | $0.34 | $0.13 | $0.54 | $0.03 | ($0.90) |
| |
| Shares outstanding (basic) | 4.7 | 4.8 | 4.9 | 4.9 | 5.0 | 5.1 | 5.1 | 5.1 |
| Shares outstanding (diluted) | 4.7 | 4.8 | 4.9 | 4.9 | 5.0 | 5.1 | 5.1 | 5.1 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |